Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
1 About the SELECT trial and SCORE real-world study SELECT was a randomized, double-blind, parallel-group, placebo-controlled trial designed to evaluate the efficacy of Wegovy (semaglutide) 2.4 mg versus placebo as an adjunct to standard of care for the prevention of MACE in people with overweight or obesity and established CVD with no prior history of diabetes
Regeneron is betting big on that difference
The dual mechanism genuinely adds something new, and for many patients, its the change that restarts meaningful progress
,
US$ 20.65
US$ 29.24
US$ 21.39
US$ 21.34
US$ 27.39
US$ 20.63
